The Michael Brady Lynch Firm’s Lead Trial Attorney and firm founder Michael Brady Lynch, Esq. with Managing Associate Attorney, Jaime E. Moss, Esq. along with associates from Peiffer Rosca Wolf Abdullah Carr & Kane took a stand for victims of Onglyza cardiac injuries by filing with the U.S. District Court for the Eastern District of California against Bristol-Myers Squibb and AstraZeneca Pharmaceuticals alleging wrongful death, negligence, failure to warn and other counts.
About Onglyza
When Onglyza (saxagliptin) arrived on the market in 2009, it was seen as a new frontier in maintaining blood sugar levels in type 2 diabetics. The excitement faded when the drug was linked to heart failure and other serious complications.
Ongoing litigation alleges that AstraZeneca likely knew Onglyza had the potential for heart failure as early as 2006. This is three years before the FDA approved the drug. Heart failure is a potentially deadly condition. It arises when the heart does not pump blood thoroughly enough to satisfy the needs of the body. According to the Centers for Disease Control and Prevention, heart failure contributed to 1 in every 9 deaths in the U.S. in 2009. Half of all people who develop heart failure will die within 5 years of the diagnosis, according to the CDC.
The FDA didn’t even know that Onglyza was killing people until 2014. This is 5 years after approval. This is when the FDA demanded an investigation into the link between saxagliptin use and heart failure.
Onglyza Cardiac Litigation
On March 29, The Michael Brady Lynch Firm along with Peiffer Rosca Wolf Abdullah Carr & Kane filed Lori Stewart’s case on behalf of the estate of her mother, Agnes Stewart in the U.S. District Court for the Eastern District of California against Bristol-Myers Squibb and AstraZeneca Pharmaceuticals. Lori Stewart says the manufacturers committed wrongful death, negligence, failure to warn and other counts against her mother.
Between February and June 2015, her mother, Agnes Stewart used Onglyza as part of her diabetes treatment, but she developed congestive heart failure in June 2015. Her daughter insists that pharmaceutical giants never warned her mother of the cardiac risks of using Onglyza and saxagliptin. Lori Stewart requested a jury trial for compensatory, general and punitive damages; incidental expenses; prejudgment interest; and for other such and further relief as the court deems just and proper.
Get the Onglyza Cardiac Injury Experts to Represent You
The Michael Brady Lynch Firm is still accepting cases in all 50 states. We represent those who took Onglyza or Kombiglyze XR and experienced heart failure. Saxagliptin medications like Onglyza and Kombligyze XR have hurt thousands of people. It is also important to contact a law firm that has experience and resources to get the compensation you deserve if you or a loved one took Onglyza and suffered heart failure. The Michael Brady Lynch Firm is that firm. We have decades of experience in recovering millions of dollars for our clients. This is why we have received a high degree of peer recognition and professional achievement. These include inclusion on numerous Plaintiff Steering Committees. We will take whatever legal measures are necessary when fighting for your rights to damages.
